Ocular Therapeutix
OCUL
OCUL
182 hedge funds and large institutions have $1.44B invested in Ocular Therapeutix in 2025 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 74 increasing their positions, 48 reducing their positions, and 31 closing their positions.
Holders
182
Holders Change
-14
Holders Change %
-7.14%
% of All Funds
2.44%
Holding in Top 10
10
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.13%
New
22
Increased
74
Reduced
48
Closed
31
Calls
$8.78M
Puts
$3.94M
Net Calls
+$4.84M
Net Calls Change
+$1.86M
Top Buyers
1 |
![]()
1
Fidelity Investments
Boston,
Massachusetts
|
$182M |
2 |
PBA
2
Paradigm Biocapital Advisors
New York
|
$31.7M |
3 |
3
Invesco
Atlanta,
Georgia
|
$14.3M |
4 |
4
UBS Group
Zurich,
Switzerland
|
$18.2M |
5 |
5
Raymond James Financial
St Petersburg,
Florida
|
$8.21M |